OSSEOINTEGRATION IMPLANTS MARKET ANALYSIS

Osseointegration Implants MarketSize and Trends

The global osseointegration implants market is estimated to be valued at US$ 7,558.90 million in 2022 and is expected to exhibit a CAGR of 6.3% during the forecast period (2022-2030).

Figure 1. Global Osseointegration Implants Market Share (%), by Product Type, 2022

Growing number of joint replacement surgeries among geriatric population is expected to drive the osseointegration implants market growth

Increasing patient population undergoing joint replacement surgeries has boosted growth of the global osseointegration implants market. For instance, in June 2019, according to the data published by the National Center for Biotechnology Information, approximately 40 percent of the global population over age 55 experiences chronic knee pain, of those, 50.8 million suffer from disabling pain, and about 2.6 million turn to knee replacement surgery each year. Approximately 0.8 percent of Americans are living with a hip replacement, and 1.5 percent with a knee replacement. More women are living with prosthetic hips and knees than men. The survey included 18 countries with a total population of 755 million, and an estimated 1,324,000 annual primary and revision total knee procedures. According to the National Joint Registry (NJR), in 2017, around 992,090 primary total hip replacements, 1,087,611 knee replacements, 4,687 ankle replacements, 30,720 shoulder replacements, and 2,872 elbow replacements were performed in the U.K. Moreover, in the U.S, around 17,500 new Spinal Cord Injury (SCI) cases were performed annually and an estimated 285,000 people were suffering from SCI in 2017, as per National Spinal Cord Injury Statistical Center (NSCISC).

Figure 2. Global Osseointegration Implants Market Share (%), by Region, 2022

Increasing demand for cosmetic dentistry is expected to drive the global osseointegration implants market over the forecast period

Increasing demand for cosmetic dentistry, owing to rising prevalence of dental decays is supporting growth of the global osseointegration implants market. For instance, in March 2022, according to the World Health Organization, it is estimated that oral diseases affect nearly 3.5 million people globally. According to the WHO, 60–90% of children are affected by dental caries. Untreated dental caries (tooth decay) in permanent teeth is the most common health condition according to the Global Burden of Disease 2019. According to the U.S. Department of Health and Human Services, in 2018, the prevalence of total dental caries among the age group aged 2–19 years was 45.8% and it increases with age, from 21.4% (among age group 2–5) to 50.5% (among age group 6–11) and 53.8% (among age group 12–19) in 2016. Moreover, growing disposable incomes in various countries has also influenced growth of the osseointegration implants market.

Global Osseointegration Implants Market– Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization had declared it a public health emergency on January 30, 2020.

COVID-19 can affect the economy in three main ways: by directly affecting production and demand of drugs, medical devices, etc., by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries, such as China, India, Saudi Arabia, U.A.E., Egypt, and others, are facing problems with regards to the transportation of drugs from one place to another.

However, the COVID-19 pandemic had a negative impact on the global osseointegration implants market, owing to the decrease in number of osseointegration surgeries. For instance, in May 2020, according to the National Center for Biotechnology Information, surgical practices had been significantly impacted with all specialties writing guidelines for how to manage during this crisis. The surgeons were busy in helping the other doctors during the coronavirus pandemic time period. The main focus was to treat the COVID patients with correct medication treatment and prevent spreading of the coronavirus. The COVID 19 pandemic put restriction on the dental implant surgeries and other osseointegration surgeries to avoid the spread of coronavirus disease among the surgeons, patients and the corona infected patients within the clinics and hospitals.